Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

arGEN-X, a clinical-stage biopharmaceutical company focused on developing differentiated therapeutic antibodies for treating cancer and severe autoimmune diseases, has formed a long-term strategic alliance with Shire Pharmaceuticals. The multi-year...

Citing family reason, Marijn Dekkers, CEO of Bayer AG, will step down at the end of 2016. To ensure continuity in key aspects of Bayer's future development, Bayer's supervisory board has appointed Werner Baumann, currently chief...

Adaptimmune Limited, an UK-based biotechnology company developing T-cell receptor (TCR) engineered T-cells to treat cancer, has entered into a strategic collaboration and licensing agreement with GlaxoSmithKline (GSK) for the development...

Zydus Pharmaceuticals USA Inc., part of the the pharmaceutical company Zydus Cadila, has issued a voluntary Class II recall of 10,200 bottles of promethazine hydrochloride tablets, USP, 25 mg, 100 prescription only, due to the presence of...

Actavis plc it has entered into an agreement with Cephalon, Inc. to settle all outstanding patent litigation related to Actavis' generic version of Nuvigil  (armodafinil tablets, 50 mg, 100 mg, 150 mg, 200 mg and 250 mg). Nuvigil is a...

Bayer has entered into a global agreement with Orion Corporation, a pharmaceutical company based in Espoo, Finland, for the development and commercialization of the compound ODM-201, an investigational novel oral androgen receptor inhibitor....

AbbVie Inc. has opened the company's newly expanded manufacturing facility in Sligo, Ireland. The expansion provides increased manufacturing capacity for the company's existing product portfolio as well as new therapies within the company's...

As part of a strategy to increase its position in pain care, Teva Pharmaceutical Industries Ltd. has agreed to acquire Labrys Biologics, Inc., a privately held development-stage biotechnology company focused on treatments for chronic migraines and...

Takeda Pharmaceutical Company Limited and its wholly owned subsidiary, Takeda Pharmaceuticals International GmbH, report that the European Commission has granted marketing authorization for Entyvio (vedolizumab), a gut-selective humanized...

Eli Lilly and Company will begin sharing its clinical trial data with scientific researchers through www.clinicalstudydatarequest.com. This website, which houses data from several clinical trial sponsors, was created in support of ongoing...

Sanofi and its subsidiary Genzyme report that FDA has accepted for review the company's resubmission of its supplemental biologics license application (sBLA) seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of...